REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 141 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $644,246 | +181890.4% | 16,600 | +50.9% | 0.00% | +200.0% |
| Q1 2024 | $354 | +27.3% | 11,000 | +13.4% | 0.00% | 0.0% |
| Q4 2023 | $278 | +59.8% | 9,700 | +54.0% | 0.00% | 0.0% |
| Q3 2023 | $174 | +286.7% | 6,300 | +270.6% | 0.00% | – |
| Q2 2023 | $45 | -99.6% | 1,700 | +466.7% | 0.00% | – |
| Q4 2020 | $11,000 | -91.9% | 300 | -92.3% | 0.00% | -100.0% |
| Q3 2020 | $135,000 | +9.8% | 3,900 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $123,000 | +57.7% | 3,900 | +8.3% | 0.00% | – |
| Q1 2020 | $78,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,909,317 | $66,444,000 | 43.13% |
| TRV GP III, LLC | 8,024,031 | $279,236,000 | 23.46% |
| Svennilson Peter | 7,977,384 | $277,613,000 | 22.65% |
| TRV GP IV, LLC | 1,419,900 | $49,413,000 | 17.01% |
| Trustees of Princeton University | 90,758 | $3,158,000 | 4.22% |
| BVF INC/IL | 2,101,049 | $73,117,000 | 3.98% |
| Boxer Capital, LLC | 3,309,264 | $115,162,000 | 3.98% |
| Cormorant Asset Management, LP | 2,640,177 | $91,878,000 | 3.53% |
| Copernicus Capital Management, LLC | 81,000 | $2,819,000 | 2.68% |
| Casdin Capital, LLC | 1,634,535 | $56,882,000 | 2.55% |